I agree that this site is using cookies. You can find further informations here.
X
Laharie, D.
749  results:
Search for persons X
?
1

P173 Characterization of the gut microbiota and the colonic..:

Riviere, P ; Dallmann-Sauer, M ; Enaud, R...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i479-i479 , 2024
Link: https://doi.org/10.1093/..
 
?
2

P927 Long-term outcomes of risankizumab in Crohn's disease:..:

Fumery, M ; Caron, B ; Hébuterne, X...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1686-i1686 , 2024
Link: https://doi.org/10.1093/..
 
?
3

P678 Long-term efficacy, safety and health-related quality ..:

Feagan Senior Scientific Officer, B G ; Matsuoka, K ; Rogler, G...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1288-i1289 , 2024
Link: https://doi.org/10.1093/..
 
?
4

P456 Pragmatic trial design to compare real-world effective..:

Fantini, M C ; Fiorino, G ; Colli, A...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i922-i923 , 2024
Link: https://doi.org/10.1093/..
 
?
5

P322 Compared Efficacy of Second-Line Treatments for Ulcera..:

Calmejane, L ; Reenaers, C ; Amiot, A...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i707-i707 , 2024
Link: https://doi.org/10.1093/..
 
?
6

P857 Effectiveness and safety of subcutaneous infliximab in..:

Andre, M ; Kirchgesner, J ; Laharie, D...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1587-i1587 , 2024
Link: https://doi.org/10.1093/..
 
?
7

P932 Corticosteroid-sparing effect of mirikizumab for the t..:

Laharie, D ; Siegel, C ; Dulai, P...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1697-i1698 , 2024
Link: https://doi.org/10.1093/..
 
?
8

P943 Real world Effectiveness and safety of tofacitinib in ..:

Fumery, M ; Bouhnik, Y ; Faure, P...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1717-i1718 , 2024
Link: https://doi.org/10.1093/..
 
?
9

P900 A PROOF-OF-CONCEPT, PLACEBO-RANDOMIZED CONTROLLED TRIA..:

Carbonnel, F ; Barnich, N ; Hébuterne, X...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1650-i1650 , 2024
Link: https://doi.org/10.1093/..
 
?
10

OC.07.3: CORTICOSTEROID-SPARING EFFECT IN PATIENTS WITH MOD..:

Laharie, D. ; Siegel, C.A. ; Samaan, K....
Digestive and Liver Disease.  56 (2024)  - p. S163-S164 , 2024
Link: https://doi.org/10.1016/..
 
?
11

DOP65 Infliximab plus azathioprine and quick steroids disco..:

Amiot, A ; Seksik, P ; Meyer, A...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i191-i191 , 2024
Link: https://doi.org/10.1093/..
 
?
12

DOP23 The role of histology for the prediction of clinical ..:

Reenaers Dr, C ; Enea, D ; Nachury, M...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i117-i117 , 2024
Link: https://doi.org/10.1093/..
 
?
13

OP35 Efficacy of mirikizumab in comparison to ustekinumab i..:

Jairath, V ; Sands, B E ; Bossuyt, P...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i62-i64 , 2024
Link: https://doi.org/10.1093/..
 
?
14

P766 No difference in progression of disability 2 years aft..:

Vieujean, S ; Desseaux, K ; Laharie, D...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1429-i1431 , 2024
Link: https://doi.org/10.1093/..
 
?
15

P903 Persistence, efficacy and tolerance of subcutaneous In..:

Mathieu, N ; Heluwaert, F ; Riviere, P...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1655-i1655 , 2024
Link: https://doi.org/10.1093/..
 
1-15